According to Article 12 of the Regulations for Medicament Contract Manufacture and Analysis, an entity that conforms to any of the following descriptions may accept a contract for the analysis of drug products:

1. 1. A medicinal product factory that is in compliance with the Regulations Governing Good Manufacturing Practices for Medicinal Products.
2. 2. A domestic or foreign academic research institute that meets the requirements of good laboratory practices for non-clinical laboratory studies.
3. 3. An analysis institution or laboratory that meets the certification requirements under Article 104-4 of the Pharmaceutical Affairs Act.
4. 4. Other entity certified on an ad-hoc basis by the competent central health authority.

(中文版)